Device

Shurink Universe

Korean-made focused ultrasound, MFDS-approved (21-831), with facial cartridges at 1.5 / 2.0 / 3.0 / 4.5 mm. Not FDA-cleared in the US. It treats at the same depths as Ultherapy — the difference is imaging, not depth.

What it is

Korean-made focused ultrasound approved by Korea's MFDS. Approved uses include brow lifting and improvement of wrinkles around the eyes, mouth and neck, with separate body cartridges approved in 2025 for elasticity of the abdomen and thighs. It generates thermal coagulation points at selected depths, which prompts collagen remodelling. Not FDA-cleared in the United States.

Verified
2026-08-22

Treatment depths

Facial cartridges at 1.5 / 2.0 / 3.0 / 4.5 mm.

Verified
2026-08-22

Who it suits

Treats at the same depths as Ultherapy, so the tissue it can reach is the same. Where the two differ is in how depth is confirmed during treatment — Ultherapy images the tissue in real time, while Shurink relies on anatomical landmarks and operator experience. Neither is better as a device; the difference matters most where tissue thickness is unpredictable.

Verified
2026-08-22

What to expect

You can return to normal activities and wear makeup immediately after treatment. Mild swelling and flushing are common straight afterwards; sunscreen and a moisturiser are advised. The manufacturer does not publish a fixed shot count — the recommended number varies with your skin condition, the degree of laxity and the area treated, which is why it is decided at consultation rather than quoted in advance.

Verified
2026-08-22
Related

Concerns this addresses

Not sure this is the right treatment?

Send your concern, travel dates and budget. A coordinator asks the clinics on your behalf and replies in English with options — including treatments you may not have considered.

Start free consultation

General guidance, not medical advice. This page does not describe results you should expect. Outcomes vary and every procedure carries risks that should be discussed with a licensed physician. Treatment suitability is confirmed by the clinic at consultation.

Cleared indications and treatment depths are as published by the device manufacturer; actual depth reached varies with transducer selection, settings and individual anatomy. Comparative statements describe published device specifications, not the relative quality of any clinic or physician.

Where prices are shown, they are ranges drawn from the non-reimbursable treatment costs partner clinics publish under Article 45 of Korea's Medical Service Act. They are not quotes, offers or discounts, and your final price is confirmed by the clinic.

Device and product names are registered trademarks of their respective owners. KRACE and 알앤피티 주식회사 are not affiliated with, endorsed by, or sponsored by any of these companies. Device names are used only to identify treatments offered by partner clinics.

Regulatory statements are current as of August 2026.

KRACE is a healthcare curation and coordination service operated by 알앤피티 주식회사 (RnPT Inc.), registered for foreign patient attraction, intended for patients residing outside Korea. KRACE does not provide medical services and does not charge patients a coordination fee.